Samante, Reniel Jay A.

HRN: 22-95-41  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/24/2023
05/01/2023
IV
1g
Q6
PCAP
Waiting Final Action 
04/25/2023
MUPIROCIN 2%, 15G (TUBE)
04/25/2023
05/02/2023
TOPICAL
Pea Size
BID
Staph Skin Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: